Hyperlipidemia News and Research

RSS

Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

In a recent study posted to the medRxiv* preprint server, researchers investigated the incidence of cardiac AESIs (adverse events of special interest) among Kaiser Permanente Northwest (KPNW) members who had received JYNNEOS vaccinations against the monkeypox (MPX) virus.

16 Nov 2022

Mercury exposure during pregnancy could boost growth rates of fetus and infant

In a new study, researchers used a physiologically-based pharmacokinetic (PBPK) model to calculate the predicted concentration of MeHg in a given organ with time.

10 Nov 2022

Study calls for stronger awareness and control of vascular risk factors leading to stroke

Researchers at the Stroke Research and Prevention Group (HKU Stroke), Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) found that the incidence of 'young stroke' (strokes occurring in individuals aged 18 to 55 years) has increased by 30% in Hong Kong from 2001 to 2021, thus called for better control of vascular risk factors, in particular hypertension.

31 Oct 2022

Male mice three times more likely than females to survive E. coli infection

Scientists at UC San Francisco have developed a new way of looking at sex-biased diseases that is rooted in evolutionary biology.

20 Oct 2022

Study shows how feasible reductions in ultra-processed food consumption positively impact the nutritional quality of diets

Researchers assessed the association between consumption of ultra-processed food and dietary nutrient profiles.

8 Sep 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

COVID-19 impairs the insulin/IGF signaling pathway

Scientists evaluate the impact of SARS-CoV-2 on the insulin/IGF signaling pathway.

6 Jul 2022

Acute scrotal infections among COVID-19 patients significantly associated with disease severity in new study

In a new study, researchers assessed the influence of severe coronavirus disease 2019 on scrotal infections.

5 Jul 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

Height increases risk of certain diseases

In a recent study published in the Journal PLoS Genetics, researchers investigated how height determined several common clinical traits in adults by comparing associations of those traits with actual- and genetically-predicted-height.

5 Jun 2022

New mouse model shows the connection between stress, depression and cardiovascular disease risk

Results from a new mouse model may aid in understanding how depression and prolonged and severe stress increase the risk of cardiovascular disease, according to preliminary research presented at the American Heart Association's Vascular Discovery: From Genes to Medicine Scientific Sessions 2022.

13 May 2022

Researchers uncover a new protective mechanism against non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD), commonly known as fatty liver disease, is a prevalent disease frequently seen in obese people. Having high fat content in the liver is detrimental as it is strongly associated with severe health problems like diabetes, high blood pressure, and liver cancer.

20 Apr 2022

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Researchers demonstrate that avasimibe-mediated inhibition of ACAT blocks the entry and fusion of SARS-CoV-2 in different cell types.

18 Apr 2022

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

A recent study posted to the medRxiv* preprint server investigated the association of renin-angiotensin-aldosterone system (RAAS)-mediated hypertension (HT) with coronavirus disease 2019 (COVID-19).

6 Apr 2022

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

Researchers examined the post-acute risk and burden of incident diabetes beyond the initial 30 days of COVID-19.

25 Mar 2022

Hispanic/Latino youth with food insecurity have worse cardiometabolic profiles, study shows

Hispanic/Latino youths with limited access to nutritionally adequate food – and especially those whose parents were foreign-born -- had worse cardiometabolic profiles than their "food secure" counterparts, according to a study published in Pediatrics.

17 Mar 2022

Hyperlipidemia News and Research

Further Reading

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

Mercury exposure during pregnancy could boost growth rates of fetus and infant

Study calls for stronger awareness and control of vascular risk factors leading to stroke

Male mice three times more likely than females to survive E. coli infection

Study shows how feasible reductions in ultra-processed food consumption positively impact the nutritional quality of diets

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

COVID-19 impairs the insulin/IGF signaling pathway

Acute scrotal infections among COVID-19 patients significantly associated with disease severity in new study

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Height increases risk of certain diseases

New mouse model shows the connection between stress, depression and cardiovascular disease risk

Researchers uncover a new protective mechanism against non-alcoholic fatty liver disease

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

Hispanic/Latino youth with food insecurity have worse cardiometabolic profiles, study shows

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Biomedical characterization of quantitative proteomics in a hospitalized cohort of COVID-19 patients

Study suggests history of childhood traumas may increase the risk of long COVID

Basic health beliefs and demographics associated with risk factors for cardiovascular disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News